Amicus Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
FOLD Nasdaq 2830 amicusrx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amicus Therapeutics, Inc.

Amicus Therapeutics Announces Approval of Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) in Japan - Jun 25th, 2025 5:00 am
Amicus Therapeutics Publishes Positive PROPEL Study Data for Pompe Disease Treatment - Jun 24th, 2025 10:45 am
New Strong Sell Stocks for June 3rd - Jun 3rd, 2025 5:45 am
New Analysis of Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Published in Muscle and Nerve - Jun 3rd, 2025 5:00 am
Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025 - May 30th, 2025 5:00 am
3 High Growth Tech Stocks In The US Market - May 21st, 2025 11:41 am
Is Amicus Therapeutics (FOLD) the Best Low Priced Biotech Stock to Buy Now? - May 13th, 2025 6:51 am
Amicus Therapeutics to Present at the Bank of America 2025 Health Care Conference - May 7th, 2025 5:00 am
Amicus Therapeutics First Quarter 2025 Earnings: Misses Expectations - May 4th, 2025 7:00 am
FOLD Q1 Earnings and Sales Miss Estimates, Stock Falls - May 2nd, 2025 11:18 am
Dimerix and Amicus to commercialise DMX-200 in US - May 1st, 2025 8:44 am
Amicus Therapeutics (FOLD) Q1 Earnings and Revenues Lag Estimates - May 1st, 2025 6:15 am
Amicus Therapeutics: Q1 Earnings Snapshot - May 1st, 2025 5:17 am
Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates - May 1st, 2025 5:00 am
Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States - Apr 30th, 2025 5:12 pm
Earnings Preview: Y-mAbs Therapeutics, Inc. (YMAB) Q1 Earnings Expected to Decline - Apr 29th, 2025 8:01 am
Amicus Therapeutics (FOLD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Apr 24th, 2025 8:01 am
Is Amicus Therapeutics, Inc. (FOLD) Among the Best Guru Stocks to Buy According to Wall Street Analysts? - Apr 23rd, 2025 10:57 am
Amicus Therapeutics to Report Q1 Earnings: What's in the Cards? - Apr 23rd, 2025 7:25 am
Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025 - Apr 21st, 2025 5:00 am